KAUST researchers introduce deepBlastoid, an AI platform automating and standardizing classification of human blastoids from brightfield images with high accuracy and efficiency.
Key Details
- 1deepBlastoid uses a ResNet-18 architecture to classify human blastoid images in five categories.
- 2The curated dataset includes 17,133 brightfield images, with 2,407 expert-labeled.
- 3Achieved up to 97% accuracy by combining the base model (87%) with a Confidence Rate metric for expert fallback.
- 4Processes 273.6 images per second—1,000 times faster than human experts.
- 5Tool validated in drug dose optimization and safety assessment use cases.
- 6Publicly available tools and dataset support global research customization.
Why It Matters
DeepBlastoid exemplifies the potential of AI-powered image analysis for scalable, objective, and reproducible evaluation in developmental biology—a workflow parallel to emerging radiology and digital pathology automation. Its open-source tools may inspire similar strategies for image-intensive tasks in radiology and pathology.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.